Health & Wellness


'Keto Clarity' details the many health benefits of ketogenic diet

 Jimmy Moore
Obesity expert Jimmy Moore lost 180 pounds on the ketogenic diet.
The ketogenic diet has proven effective for accelerating weight loss, but also manages epilepsy, reverses type 2 diabetes, and prevents heart disease, dementia and cancer.

In the book, Keto Clarity, author Jimmy Moore outlines the many health benefits of the ketogenic diet and how he used the low-carb, high-fat eating plan to lose 180 pounds.

In researching his book, Moore spoke to a respected panel of experts, including renowned cancer scientist Dr. Thomas Seyfried, whose decades of research indicate the ketogenic diet starves cancer and beats chemotherapy for most cancers.

Moore's co-author is nationally recognized obesity expert Dr. Eric Westman, author of the bestseller New Atkins for a New You.

Over the years, Dr. Westman has helped thousands of morbidly obese people lose hundreds of thousands of pounds by following a low-carb, high-fat (LCHF) diet.

The LCHF diet also helped Westman's patients reverse their type 2 diabetes, improve their cholesterol profile, and dramatically reduced their risks of heart disease.

Pfizer lawsuits mount due to Lipitor side effects

© Natural News
Pfizer lawsuits mount due to Lipitor side effects as more women file claims against the gigantic pharmaceutical company. So far, close to 1,000 cases, representing over 4,000 women were filed against the huge drug manufacturer. The women allege that Pfizer did not give the public proper warning about the side effects of Lipitor.

Pfizer lawsuits mount due to Lipitor side effects

Lipitor became available to the public in 1996; it is the best-selling pharmaceutical drug, ever. Globally, sales of Lipitor are close to 130 billion dollars. It is prescribed to around 29 million patients in the United States.

Within the last five months, American women filed lawsuits in federal court against Pfizer. The women claim Lipitor caused them to develop Type-2 diabetes and Pfizer failed to warn them. Lawsuits increased substantially after the U.S. Food and Drug Administration (FDA) provided a warning in 2012 linking statins, including Lipitor, to incidents consisting of "a small increased risk of raised blood sugar levels and the development of Type 2 diabetes" and reports of memory loss. Presently, the FDA substantiates that the benefits of statins and Lipitor outweigh the risks.

Statins help in lowering cholesterol levels; however, like most medication, they can cause some potentially dangerous side effects, such as liver damage, neurological side effects, muscle problems, increased blood sugar, or Type-2 diabetes. Pfizer stated they plan to fight the lawsuits and they deny any liabilities.

Stress in the home & parental depression linked with childhood asthma

Researchers from the Rush University Medical Center have found that stress in the home and depression among parents increase the risk of asthma and asthmatic attacks among children.

The researchers - part of the Project CURA: The Community United to Challenge Asthma - investigated and studied the homes of Puerto Rican children between the ages of 5 and 18 years old with asthma within the city of Chicago. The research was funded by the National Heart Lung and Blood Institute of the National Institutes of Health.

Curiously, Puerto Rican children have a far greater risk of asthma than do white, black or hispanic children. An asthma study published in the Journal Pediatrics in 2006 found that 26% of Puerto Rican children had been diagnosed with asthma between 1997 and 2001 while only 12% of white children, 16% of black children, 12% of hispanic children had been diagnosed with asthma during the same period. This means that Puerto Rican children have more than double the asthma rates of most other children.
Alarm Clock

One little piggy had birth defects: Is Monsanto's Roundup to blame?

© Jan Ingemansen / Flickr
A pig farm in Denmark. A renewed charge against Monsanto's Roundup pesticide is being led by a Danish pig farmer who realized the chemical's effects on his livestock.
One little piglet was born with only one large eye. A second piglet was missing an ear. A third piglet had a large hole in its skull. A fourth piglet had a monstrously huge "elephant tongue." A female piglet was born with testes. Still others had malformed limbs, spines, skulls and gastrointestinal tracts.

The pigs in question belonged to a Danish pig farmer. For three years he had fed his pigs ordinary, non-genetically modified soy. When he ran out, he bought the cheaper genetically modified (GM) soy pig feed. His herdsman, unaware of the feed switch, immediately noticed that the pigs lost their appetite and that the piglets developed diarrhea. Even worse was the sudden and shocking increase in birth defects. The farmer, eager to understand the cause, had 38 of the deformed pigs euthanized and tested for glyphosate, the herbicide used on the GM soy. The results were published in the April 2014 issue of the Journal of Environmental and Analytic Toxicology. The samples of lung, liver, kidney, brain, gut wall, heart and muscle all tested positive.

Comment: Read more about Glyphosate: A trajectory of human misery:

Life Preserver

Benefits of chiropractic adjustments

If you haven't visited a chiropractor before, you might be missing out. Millions of people around the world have experienced the incredible benefits of chiropractic care.

One of the best things about chiropractic care, is that it is a drug-free and surgery-free path to healing naturally.

People have reported chiropractic benefits help to improve:
  • Back pain
  • Headaches
  • Ear infections
  • Neck pain
  • Arthritis and joint pain
  • Scoliosis
  • Asthma
  • Blood pressure
  • Healthy pregnancy
  • Organ function
  • Surgery prevention
There are a lot of misconceptions about chiropractic and how chiropractors are trained. In fact, did you know many chiropractic programs also incorporate an entire year of PhD level advanced nutrition training?

However, most of the benefits of seeing a chiropractor come from getting a chiropractic adjustment. Let's talk about the philosophy, history and evidence-based research of chiropractic care.

GMO Golden Rice in Asia: Problem, reaction, solution

GMO protest
© shutterstock
Asia's dependency on rice cultivation for both subsidence and income is intuitively understood. The Food and Agricultural Organization of the United Nations (FAO) estimates the agricultural population of lowland rice cultivation in Asia to be over 470 million - larger than the entire population of the United States. Improvements in rice cultivation would stand to lift hundreds of millions from debt and poverty. Conversely, the disruption of rice cultivation would threaten to mire hundreds of millions in deeper debt, inescapable destitution, and all of the negative socioeconomic implications that follow.

Asia's rice farmers produce between 1-2 harvests a year depending on the climb and climate of any given region. They do so to sell their rice, generally to mills who in turn sell the final product to exporters or for domestic consumption. Out of each harvest, rice farmers keep a portion for their own consumption, but the vast majority of what they grow is for income.

The UK-based Rice Association claims there are up to 40,000 species of rice, with a wide variety of characteristics suitable for different markets and uses. Rice farmers grow those which local, national and regional markets are best suited to move. In nations where subsidies are offered for rice crops, cheap, easy to grow varieties are chosen. More desirable or exotic species are grown by independent farmers who have developed their own cooperative with millers, marketers and exporters. The rice Asians eat depends on both economic and market realities. The impoverished eat what is cheapest and most easily available, but not necessarily that which is healthiest.
Arrow Down

Thanks to current guidelines - Heart attacks '50,000 higher' in the UK

The British Heart Foundation says one person is having a heart attack every three minutes.
The number of heart attacks in the UK is 50,000 higher than previously thought, according to figures from the British Heart Foundation.

The charity said numbers are 35% higher than estimates have suggested, with around 175,000 heart attacks thought to take place each year.

The figures translate to one person having a heart attack every three minutes, the charity said.

Comment: That kind of research has been in the works for quite some time now and it is common knowledge in some circles. In fact, current guidelines look like barbaric recommendations worthy of a medical museum. About everybody who follows them end up with cardiovascular disease, that has been the trend during the last decades and expecting something different is the very definition of insanity.

The question is, would mainstream science finally catch up for the sake of the population they are supposed to take care? For more information, see:

- From the Heart: Saturated fat is not the major issue
- Swedish Expert Committee: A Low-Carb Diet most effective for weight loss
- The Ketogenic Diet - An Overview
- Saturated fat heart disease 'myth': UK cardiologist calls for change in public health advice on saturated fat
- Heart surgeon speaks out on what really causes heart disease


Restrictions eased by FDA on experimental Ebola drug as CDC warns of inevitable spread to U.S.

vials of test drugs
Ebola drug option receives preliminary go-ahead.
While Ebola, the deadly disease spreading through parts of West Africa, has no cure, specific treatment or vaccine, there are several experimental drugs being tested in US labs. Now the FDA has lifted its hold on one of those drugs.

The US Food and Drug Administration gave Tekmira Pharmaceuticals verbal confirmation that they modified the full clinical hold the regulatory agency had placed on the company's experimental TKM-Ebola drug, enabling the potential use on Ebola patients, Tekmira said in a statement.

"We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so," said Dr. Mark Murray, CEO and president of Tekmira.

"This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols."

The company, in collaboration with infectious disease researchers from Boston University and the United States Army Medical Research Institute for Infectious Diseases, showed the drug's ability to protect non-human primates from Ebola in preclinical trials in May 2010, Tekmira said.
A Phase I clinical trial ‒ the first step towards FDA approval ‒ began on humans in January. The agency then approved a fast-track designation for the drug in March, around the same time the Ebola outbreak began in Guinea, Liberia and Sierra Leone. It has since spread to Nigeria. According to World Health Organization figures published on Wednesday, there are over 1,700 suspected and confirmed cases of Ebola in the four countries, and 932 of those patients have died from the disease.
A different drug, ZMapp by Mapp Biopharmaceutical Inc., was used to treat two American aid workers who had contracted Ebola in Liberia. ZMapp, previously only known as "a secret serum," has not been given the go-ahead to begin human trials yet, Forbes reported. It works by boosting the immune system to battle against Ebola. The treatment consists of antibodies from lab animals exposed to the virus.

Comment: Timing? Phase1 clinical trials of TKM-Ebola began simultaneously with the outbreak of the virus in Sierra Leone, Liberia and Guinea in March. Depending on the "specific population" a FDA assessment is created for an acceptable "risk-benefit balance" in order to "fast-track the development and expedite the review of drugs to fill an unmet medical need." Purportedly, TKM-Ebola is considered the best-positioned drug that could be stockpiled by the U.S. Department of Defense. Securing this stockpiling contract, Tekmira could receive annual cash flows of $75M for both TKM-Ebola and TKM-HBV. Tekmira Pharmaceuticals increased their stock shares worth over 75% since July 22...well before the fast-track announcement on August 3, 2014, supposedly spurred on by the serum given to Brantley and Writebol. The experimental serum given to U.S. healthcare workers was ZMapp, not TKM-Ebola. Hmmm...

Looking more closely..."Tekmira has long been a partner for the biotech companies receiving royalties for products relying on its delivery technology. However, that changed with the announcement Monsanto (MON) would be licensing Tekmira's intellectual property to develop weed and pest control and virus suppression products. In return for a near term payment of $16.5 million and ongoing future payments as milestones are met, Tekmira is providing lipid formulations to Monsanto along with the option to purchase the worldwide rights to its technology. In all, the contract could potentially be worth $86.2 million over the four year option period." Tekmira Signs Development Agreement on Delivery Technology for Agricultural Applications

Itty bitty questions anyone?


Slowing brain functions linked to increased risk of stroke, death

Low cognitive function is generally associated with poor neurological health and brain function. Worsening of neurological health can lead to several health problems with stroke being one of them.
Cognitive abilities such as memory and attention are not only important after a stroke but also before; according to Declining memory and cognitive ability may increase the risk of stroke in adults over age 65. After stroke, cognitive function declined almost twice as fast. Stroke and cognitive decline increased the risk of death in older adults.

Research published in the American Heart Association journal Stroke.

Previous studies have shown poor cardiovascular health can increase the risk of cognitive impairment such as problems in memory and learning. However, the opposite idea that cognitive impairment may impact cardiovascular health, specifically stroke, was not established before.

Fears tiger mosquito could bring dengue fever to France

tube of mosquitos
Big things come in small packages.
Doctors on the French Riviera have treated 17 people for dengue fever and chikungunya this year, amid fears that a decade-long invasion of Asian tiger mosquitoes in the region could spread the tropical diseases.

All of the infected patients had visited Brazil, where they went to see the Football World Cup, and the Caribbean. Four of them had dengue fever and 11 contracted chikungunya. Two unlucky victims came back infected with both.

The presence of Asian tiger mosquitoes in France is proving a big concern to health services because unlike native species they are able to transmit both dengue and chikungunya. The Asian tiger mosquito, which has distinctive black and white stripes, was introduced to Europe in the late 1970s via a goods shipment from China to Albania.

A subsequent introduction in Italy in the 1990s, thought to be from larvae in a delivery of car tires from the USA, led to a population explosion in Italy which gradually spread.

Asian tiger mosquito
First seen in France in 2004, the mosquitoes have now firmly established themselves along France's Mediterranean coast and are moving up the Rhône valley. In 2010, two cases of Dengue were contracted in the Riviera after mosquito bites in France itself, a nightmare scenario for local health services.

The response in the Alpes-Maritimes administrative region is aggressive.

In some cases, powerful insecticides are used to drench a 500 metre radius around the infected person to kill all mosquitoes and so guarantee the disease does not spread, according to local daily Nice Matin.

"More than that isn't really necessary," Dr Fabien Josserand of the regional council told the newspaper. "Asian tiger mosquitoes do not spread fast and rarely if ever fly more than 100 metres from where they hatch."

An estimated 400,000 French tourists visit regions with dengue fever and chikungunya every year.

Comment: Dengue is a potentially fatal fever and especially dangerous for children. 390 million people are infected per year of which about 96 million become sick, as per UN estimates. According to WHO, more than half of the world's population is now at risk of the disease. This article doesn't say what kind of "powerful insecticides" were used, but if the fever doesn't kill you, the consequences of insecticide poisoning exposure and/or the up-coming vaccine may increase those odds.